Prevalence of Ethnic Neutropenia and Duffy Null Phenotype in Neonates

Recruiting Observational Study
Neutropenia (Low White Blood Cell Count)
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
1 Minute – 1 Day
Sex
Any
Study type
Observational
Participants needed
1,000 (estimated)
Sponsor
Kaplan Medical Center · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This is a prospective observational study designed to assess the prevalence of the Duffy null phenotype (associated with ethnic neutropenia) in neonates born at Kaplan Medical Center. Blood samples will be collected from umbilical cords (non-invasively) to evaluate Duffy antigen expression. Data on ethnicity, perinatal factors, and routine blood counts at 9-12 months (when available) will also be …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Neonates born at Kaplan Medical Center between 1.9.2024 and 31.12.2025 * Parental informed consent obtained * Umbilical cord blood available for routine testing Exclusion Criteria: * None
Contacts

Tal Ben Ami, M.D

+972-50-7414922

tal.ben.ami11@gmail.com

CONTACT

Yael Zeitak, PhD

+972-52-627-4987

yaelze4@clalit.org.il

CONTACT